Jones Hill Capital LP
26 holdingsFiling period: 2026-03-31Current AUM: $493.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | BIOMARIN PHARMACEUTICAL INC | 1.27M | $71.7M | $76.1M | 15.42% | -- | 2026-03-31 |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | 108.6K | $48.5M | $51.8M | 10.49% | -- | 2026-03-31 |
| 3 | PCVX | VAXCYTE INC | 644.8K | $37.5M | $34.9M | 7.06% | -- | 2026-03-31 |
| 4 | NUVL | NUVALENT INC | 300.8K | $30.8M | $30.8M | 6.24% | -- | 2026-03-31 |
| 5 | CAPR | CAPRICOR THERAPEUTICS INC | 909.2K | $27.6M | $3.5M | 0.71% | -- | 2026-03-31 |
| 6 | TERN | TERNS PHARMACEUTICALS INC | 521.2K | $27.5M | $27.5M | 5.56% | -- | 2026-03-31 |
| 7 | BCAX | BICARA THERAPEUTICS INC | 1.26M | $25.1M | $34.1M | 6.91% | -- | 2026-03-31 |
| 8 | ANIP | ANI PHARMACEUTICALS INC | 318.6K | $24.5M | $25.2M | 5.11% | -- | 2026-03-31 |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 1.17M | $24.4M | $29.0M | 5.88% | -- | 2026-03-31 |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | 593.0K | $23.2M | $32.5M | 6.58% | -- | 2026-03-31 |
| 11 | AMLX | AMYLYX PHARMACEUTICALS INC | 1.60M | $22.2M | $32.5M | 6.57% | -- | 2026-03-31 |
| 12 | ARGX | ARGENX SE | 26.0K | $19.0M | $22.2M | 4.49% | -- | 2026-03-31 |
| 13 | FULC | FULCRUM THERAPEUTICS INC | 1.77M | $13.6M | $6.3M | 1.28% | -- | 2026-03-31 |
| 14 | VIR | VIR BIOTECHNOLOGY INC | 1.20M | $10.7M | $10.4M | 2.10% | -- | 2026-03-31 |
| 15 | NUVB | NUVATION BIO INC | 2.38M | $10.2M | $15.1M | 3.05% | -- | 2026-03-31 |
| 16 | ORKA | ORUKA THERAPEUTICS INC | 140.8K | $6.9M | $13.6M | 2.75% | -- | 2026-03-31 |
| 17 | CTNM | CONTINEUM THERAPEUTICS INC | 513.1K | $6.7M | $7.9M | 1.61% | -- | 2026-03-31 |
| 18 | MANE | VERADERMICS INC | 100.8K | $6.4M | $10.6M | 2.14% | -- | 2026-03-31 |
| 19 | TNXP | TONIX PHARMACEUTICALS HLDG C | 452.1K | $6.2M | $4.5M | 0.92% | -- | 2026-03-31 |
| 20 | GPCR | STRUCTURE THERAPEUTICS INC | 100.6K | $4.8M | $4.8M | 0.98% | -- | 2026-03-31 |
| 21 | TRDA | ENTRADA THERAPEUTICS INC | 374.0K | $4.7M | $2.5M | 0.51% | -- | 2026-03-31 |
| 22 | — | PHARVARIS N V | 167.0K | $4.7M | $4.7M | 0.96% | -- | 2026-03-31 |
| 23 | TRVI | TREVI THERAPEUTICS INC | 370.2K | $4.4M | $6.8M | 1.37% | -- | 2026-03-31 |
| 24 | RLMD | RELMADA THERAPEUTICS INC | 342.8K | $2.4M | $1.8M | 0.37% | -- | 2026-03-31 |
| 25 | SLN | SILENCE THERAPEUTICS PLC | 301.6K | $1.6M | $3.2M | 0.64% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2